JORDAN MCCLELLAN: Open Payments
NPI 1851071468 · COALPORT, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$446 in 22 payments from 14 companies in 2025. Trend: 2023 $47 · 2024 $361 · 2025 $446
Food & beverage: $446
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 2 | $52 |
| PFIZER INC. | 3 | $52 |
| Lilly USA, LLC | 2 | $44 |
| GENZYME CORPORATION | 2 | $44 |
| Ardelyx, Inc. | 2 | $40 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $36 |
| AstraZeneca Pharmaceuticals LP | 2 | $32 |
| Boston Scientific Corporation | 1 | $29 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $24 |
| Novo Nordisk Inc | 1 | $21 |
Products named: IBSRELA, XIFAXAN, QULIPTA, AIRSUPRA, NURTEC ODT, WATCHMAN FLX, CEREZYME, CAPLYTA.
Industry payments across PA — which companies pay providers there.
